The Use of Angiotensin Receptor Blockers and the Risk of Cancer
Clinical trial NCT02215733 · COMPLETED
Trial details
- NCT number
- NCT02215733
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-02-01
- Enrollment
- 1165781
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.